| Zhang, Hao |
STRATEGY, NCT05310968: Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction |
|
|
| Recruiting | 4 | 970 | RoW | Tirofiban hydrochloride sodium chloride injection, Tirofiban hydrochloride sodium chloride injection placebo, Aspirin | Beijing Tiantan Hospital, GrandPharma (China) Co., Ltd. | Branch Atheromatous Disease | 06/24 | 09/24 | | |
NCT06597201: Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. |
|
|
| Recruiting | 4 | 400 | RoW | amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution | Chengdu Qingshan Likang Pharmaceutical Co., Ltd | End Stage Renal Disease (ESRD) | 06/25 | 06/25 | | |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
NCT01954992: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
|
|
| Recruiting | 3 | 480 | US | Glufosfamide, Fluorouracil, 5-FU | Eleison Pharmaceuticals LLC. | Metastatic Pancreatic Adenocarcinoma | 06/26 | 12/26 | | |
| Suspended | 2 | 279 | Europe, US, RoW | zetomipzomib, KZR-616, placebo, matching placebo | Kezar Life Sciences, Inc. | Lupus Nephritis | 05/26 | 07/26 | | |
NCT04476485: Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy |
|
|
| Recruiting | N/A | 1000 | RoW | endocrine therapy | Shengjing Hospital | Breast Cancer | 12/21 | 12/26 | | |
NCT05296369: Folic Acid Interferes With Radiation Esophagitis |
|
|
| Recruiting | N/A | 90 | RoW | Folic acid | Guizhou Medical University | Lung Cancer | 05/23 | 05/23 | | |
| Recruiting | N/A | 620 | RoW | Lobectomy-First, Lymphadenectomy-First | Sun Yat-sen University, Tianjin Medical University Cancer Institute and Hospital, RenJi Hospital, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital of Jinan University, The First Affiliated Hospital with Nanjing Medical University, Hebei Medical University Fourth Hospital, Shanghai Changzheng Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Suining Central Hospital, Ningbo Medical Center Lihuili Hospital, Shanxi Provincial Cancer Hospital, The Affiliated Hospital of Xuzhou Medical University, The General Hospital of Eastern Theater Command, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial People's Hospital, Fujian Medical University Union Hospital, First Affiliated Hospital of Kunming Medical University, Fujian Provincial Hospital, Tianjin Chest Hospital, Sichuan Cancer Hospital and Research Institute, Shenzhen People's Hospital, Tang-Du Hospital, Shandong Provincial Hospital, Gansu Provincial Hospital, Wuhan Union Hospital, China, Wuhan TongJi Hospital, The Affiliated Hospital of Qingdao University, West China Hospital, The First Affiliated Hospital of Nanchang University, Jiangsu Cancer Institute & Hospital, Dongguan People's Hospital, First People's Hospital of Foshan | Non Small Cell Lung Cancer | 12/24 | 12/29 | | |
NCT05042531: Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia |
|
|
| Recruiting | N/A | 30 | RoW | Azacitidine, Dasatinib | LanZhou University, Beijing Health Alliance Charitable Foundation | Acute Myeloid Leukemia | 09/23 | 12/23 | | |
NCT05735262: pBFS Guided Precision Neuromodulation Treatment for ASD |
|
|
| Recruiting | N/A | 100 | RoW | active iTBS, sham iTBS | Changping Laboratory, China Rehabilitation Research Center | Autism Spectrum Disorder | 03/24 | 01/25 | | |
NCT05842304: Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT |
|
|
| Recruiting | N/A | 180 | RoW | active cTBS, sham cTBS | Changping Laboratory | Stroke, Ischemic, Aphasia | 05/25 | 05/26 | | |
NCT05475756: Safety and Efficacy of Intrauterine Biological Barrier on Postoperative Adhesion After Hysteroscopic Adhesiolysis |
|
|
| Recruiting | N/A | 264 | RoW | Intrauterine Biological Barrier, Intrauterine Adhesion Barrier Gel | Beijing Tiantan Hospital, Zhangzhou Municipal Hospital of Fujian Province, Guangzhou First People's Hospital, Tang-Du Hospital, Suzhou Municipal Hospital, Anhui Provincial Hospital | Intrauterine Adhesion | 05/24 | 05/25 | | |
NCT06499974: POASAC Study (Preoperative Anemia Severity and Classification Study) |
|
|
| Recruiting | N/A | 1000 | RoW | | Peking Union Medical College Hospital | Anemia | 12/25 | 12/26 | | |
NCT05890846: Precision TMS Treatment Guided by Personalized Brain Functional Sectors (pBFS) for ASD |
|
|
| Recruiting | N/A | 66 | RoW | active iTBS, sham iTBS, traditional 1on1 course | Changping Laboratory, Henan Provincial People's Hospital, China Rehabilitation Research Center | Autism Spectrum Disorder | 09/24 | 09/25 | | |
| Active, not recruiting | N/A | 482 | RoW | | Takeda | Multiple Myeloma, Neoplasms, Plasma Cell | 09/25 | 09/25 | | |
| Not yet recruiting | N/A | 800 | NA | | HBI Solutions Inc., Shanghai Children's Medical Center, mProbe Inc. | Kawasaki Disease | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 648 | RoW | Posterior Pericardiotomy | Changhai Hospital | Atrial Fibrillation (AF), Cardiac Events | 12/25 | 06/26 | | |
| Recruiting | N/A | 15 | RoW | Pomalidomide, Pomalyst | LanZhou University, Beijing Health Alliance Charitable Foundation | Multiple Myeloma | 05/25 | 05/25 | | |
NCT05953415: pBFS-guided iTBS Over the Left DLPFC for Chronic PSCI |
|
|
| Recruiting | N/A | 60 | RoW | active iTBS, sham iTBS | Changping Laboratory, China Rehabilitation Research Center | Chronic Stroke, Cognitive Impairment | 07/25 | 10/25 | | |
